Inditrade Capital Ltd

On 26-Nov, Inditrade Capital Ltd’s stock price fell by 4.95% to close at ₹4.80, continuing a sustained period of underperformance relative to the broader market and its sector peers.

As of 29-Oct, Inditrade Capital Ltd's stock price is at 5.21, down 4.93%, and has significantly underperformed with a year-to-date decline of 51.53%. Despite increased investor participation, the stock struggles compared to the Sensex, which has gained 8.78% year-to-date, indicating a challenging environment for the company.

As of October 23, 2025, Inditrade Capital is considered overvalued and risky due to poor financial ratios, including a PE ratio of -0.19 and a ROE of -96.06%, alongside significant underperformance with a year-to-date return of -48.47% compared to the Sensex's 8.21%.

As of 20-Oct, Inditrade Capital Ltd's stock price is at 5.71, showing a 7.53% increase after a decline, but delivery volume has dropped significantly by 69.92%, indicating reduced investor participation. Despite recent gains, the stock underperforms compared to the Sensex and has long-term declines, suggesting cautious sentiment among investors.

As of October 17, 2025, Inditrade Capital is fairly valued with a PE ratio of -0.18 and has underperformed the Sensex with a year-to-date return of -51.35%.

As of October 17, 2025, Inditrade Capital is considered fairly valued despite significant challenges indicated by a negative PE ratio of -0.18 and a year-to-date return of -51.35%, suggesting it is trading at a substantial discount compared to industry peers like Bajaj Finance and Life Insurance.

As of October 17, 2025, Inditrade Capital's valuation has improved to fair, indicating it is undervalued with a PE ratio of -0.18 and an EV to EBITDA of -1.59, significantly lower than peers like Bajaj Finance and Life Insurance, while its stock has underperformed the Sensex with a year-to-date return of -51.35%.

As of October 10, 2025, Inditrade Capital is fairly valued despite significant financial distress, reflected in its negative PE and ROE ratios, and has underperformed the market with a year-to-date return of -50.33%.

As of October 10, 2025, Inditrade Capital's valuation grade has improved to fair, but it remains under pressure with a negative PE ratio of -0.18, an EV to EBITDA of -1.59, a ROE of -96.06%, and a year-to-date stock performance decline of -50.33%, significantly lagging behind industry peers like Bajaj Finance and Life Insurance.

As of October 10, 2025, Inditrade Capital's valuation has improved to fair despite significant financial distress, with key ratios indicating undervaluation compared to peers like Bajaj Finance and Life Insurance, although it has experienced a year-to-date decline of 50.33% against a 5.58% increase in the Sensex.

As of 10-Oct, Inditrade Capital Ltd's stock price is 5.34, having increased by 5.74% recently. Despite a year-to-date decline of 50.33%, the stock shows short-term improvement, outperforming the Sensex over the past week.